Heijtz, Rochellys Diaz, Gressens, Pierre and Swann, Jonathan R. (2022) Targeting microbial metabolites to treat autism. Nature Medicine, 28 (3), 448-450. (doi:10.1038/s41591-022-01711-8).
Record type:
Article
Abstract
A first-in-class therapeutic that targets neuroactive microbial metabolites in the gut shows promising target engagement, safety and behavioral improvements in adolescents with autism spectrum disorder.
More information
e-pub ahead of print date: 14 February 2022
Published date: March 2022
Additional Information:
Funding Information:
R.D.H. is supported by the Swedish Research Council, the Swedish Brain Foundation, the Frimurare Barnhus Foundation and the European Union (ITN SmartAge, grant agreement number 859890). P.G. is supported by Inserm, the Université de Paris, the Horizon 2020 Framework Program of the European Union (grant agreement no. 874721/PREMSTEM), the ANR, the Fondation Grace de Monaco, the Fondation des Gueules Cassées and an additional grant from “Investissement d’Avenir-ANR-11-INBS-0011”–NeurATRIS. J.R.S. is supported by the National Institute for Health Research Southampton Biomedical Research Centre, Biotechnology and Biological Sciences Research Council (BB/W00139X/1) and Medical Research Council (MR/W003597/1).
Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.
Identifiers
Local EPrints ID: 455170
URI: http://eprints.soton.ac.uk/id/eprint/455170
ISSN: 1078-8956
PURE UUID: c078e950-40a7-4090-9034-4a068c045fbd
Catalogue record
Date deposited: 11 Mar 2022 17:31
Last modified: 06 Jun 2024 02:08
Export record
Altmetrics
Contributors
Author:
Rochellys Diaz Heijtz
Author:
Pierre Gressens
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.